Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Schapira

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
British Medical Bulletin|May 22, 2015
The genetics of Parkinson's diseaseStephen Mullin, Anthony Schapira
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2004
Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's diseaseAnthony Schapira, Raffaele Lodi
Molecular Neurobiology|January 31, 2013
α-Synuclein and mitochondrial dysfunction in Parkinson's diseaseStephen Mullin, Anthony Schapira
Expert Opinion on Pharmacotherapy|May 16, 2017
Safinamide for the treatment of Parkinson's diseaseRuth Mary deSouza, Anthony Schapira
Nature Reviews. Drug Discovery|August 19, 2005
RasagilineAnthony Schapira, Guy Bate, Peter Kirkpatrick
Expert Opinion on Therapeutic Targets|September 7, 2018
Chaperone-mediated autophagy as a therapeutic target for Parkinson diseasePhilip Campbell, Huw Morris, Anthony Schapira
Neurobiology of Disease|October 22, 2019
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutationShi-Yu Yang, Matthew Gegg, David Chau, et al.
Clinical Neuropharmacology|November 11, 2006
End-of-dose wearing off in Parkinson disease: a 9-question survey assessmentMark Stacy, Robert Hauser, Wolfgang Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2026
Ambroxol for Parkinson's DiseaseMarco Toffoli, Elisa Menozzi, Kashfia Chowdhury, et al.
Current Medical Research and Opinion|November 13, 2004
Diagnosing restless legs syndrome (RLS) in primary careK Ray Chaudhuri, Alison Forbes, Donald Grosset, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
British Medical Bulletin|May 22, 2015
The genetics of Parkinson's diseaseStephen Mullin, Anthony Schapira
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2004
Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's diseaseAnthony Schapira, Raffaele Lodi
Molecular Neurobiology|January 31, 2013
α-Synuclein and mitochondrial dysfunction in Parkinson's diseaseStephen Mullin, Anthony Schapira
Expert Opinion on Pharmacotherapy|May 16, 2017
Safinamide for the treatment of Parkinson's diseaseRuth Mary deSouza, Anthony Schapira
Nature Reviews. Drug Discovery|August 19, 2005
RasagilineAnthony Schapira, Guy Bate, Peter Kirkpatrick
Expert Opinion on Therapeutic Targets|September 7, 2018
Chaperone-mediated autophagy as a therapeutic target for Parkinson diseasePhilip Campbell, Huw Morris, Anthony Schapira
Neurobiology of Disease|October 22, 2019
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutationShi-Yu Yang, Matthew Gegg, David Chau, et al.
Clinical Neuropharmacology|November 11, 2006
End-of-dose wearing off in Parkinson disease: a 9-question survey assessmentMark Stacy, Robert Hauser, Wolfgang Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2026
Ambroxol for Parkinson's DiseaseMarco Toffoli, Elisa Menozzi, Kashfia Chowdhury, et al.
Current Medical Research and Opinion|November 13, 2004
Diagnosing restless legs syndrome (RLS) in primary careK Ray Chaudhuri, Alison Forbes, Donald Grosset, et al.
Pageof 2